Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by Yunggunon Dec 30, 2019 2:20pm

180 Views

Post# 30502230

RE:Warrants

Excerisable at $10. So when the Common SP is above $10, let's say $20 per share. You can exchange your 29,000 warrants for 29,000 shares at a price of $10 per share. Meaning you will have to pay an additional $290,000 to have those warrants turned into shares at $10. But if the stocks trading at $20 you shares will be worth $580,000 after conversion. I'd suggest sell while your double your money and wait for an entry point into the Common shares as they are still cheap compared to what the target price is. Personally I am taking the warrants route with a different bio tech company called tetra bio pharma. Warrants exersiable at .40 are more attractive when the SP is at .43 atm. GTLA

Bullboard Posts

Calibre discovers significant gold in Newfoundland